These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 7971472)
1. [Clinical use of hematopoietic growth factors in treatment of bone marrow failure]. Robak T; Krykowski E Pol Arch Med Wewn; 1994 Jul; 92(1):1-8. PubMed ID: 7971472 [No Abstract] [Full Text] [Related]
2. [Clinical use of hematopoietic growth factors]. Gianni AM; Bregni M; Siena S; Tarella C; DiNicola M; Bonadonna G Haematologica; 1991 Jun; 76 Suppl 3():3-10. PubMed ID: 1752526 [No Abstract] [Full Text] [Related]
3. Critical review of the role of hemopoietic growth factors in dose intensification and outcome in the treatment of non-Hodgkin's lymphoma. Canellos GP Ann Oncol; 1994; 5 Suppl 2():121-2. PubMed ID: 8204512 [No Abstract] [Full Text] [Related]
4. Biotherapy in hematology: the next decade. Quesenberry PJ Rev Invest Clin; 1994 Apr; Suppl():8-15. PubMed ID: 7886315 [No Abstract] [Full Text] [Related]
5. The use of hematopoietic growth factors to support cytotoxic chemotherapy for patients with breast cancer. Demetri GD Hematol Oncol Clin North Am; 1994 Feb; 8(1):233-49. PubMed ID: 8150782 [TBL] [Abstract][Full Text] [Related]
7. [High-dose chemotherapy with bone marrow transplantation in recurrent or refractory NHL]. Torello E; Koziner B Sangre (Barc); 1993 Dec; 38(6):473-80. PubMed ID: 7909622 [No Abstract] [Full Text] [Related]
8. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome. Beyer J; Rick O; Weinknecht S; Kingreen D; Lenz K; Siegert W Bone Marrow Transplant; 1997 Nov; 20(10):813-9. PubMed ID: 9404920 [TBL] [Abstract][Full Text] [Related]
13. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease. de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878 [TBL] [Abstract][Full Text] [Related]
14. Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies. Koumakis G; Vassilomanolakis M; Hatzichristou H; Barbounis V; Filis J; Papanastasiou K; Moraki M; Kritsioti M; Plataniotis G; Stamatelou M; Efremidis AP Bone Marrow Transplant; 1996 Dec; 18(6):1065-72. PubMed ID: 8971374 [TBL] [Abstract][Full Text] [Related]
15. Multiple myeloma: a tailored therapy for elderly patients. Pileri A; Palumbo A; Boccadoro M Hematol Oncol; 1993; 11 Suppl 1():67-72. PubMed ID: 8486344 [No Abstract] [Full Text] [Related]
16. Therapeutic potential of the hematopoietic growth factors. Usha D; Thatte UM; Dahanukar SA J Postgrad Med; 1994; 40(4):210-5. PubMed ID: 9136242 [No Abstract] [Full Text] [Related]
17. High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience. Ayash LJ; Elias A; Wheeler C; Tepler I; Schwartz G; Schnipper L; Frei E; Antman K J Hematother; 1993; 2(4):507-11. PubMed ID: 7916250 [TBL] [Abstract][Full Text] [Related]
18. Human MDR gene transfer in patients with advanced cancer. Hesdorffer C; Antman K; Bank A; Fetell M; Mears G; Begg M Hum Gene Ther; 1994 Sep; 5(9):1151-60. PubMed ID: 7833373 [No Abstract] [Full Text] [Related]
19. [Myelopoiesis and bone marrow function in elderly tumor patients]. Kolb GF Z Gerontol Geriatr; 2012 Apr; 45(3):197-200. PubMed ID: 22451304 [TBL] [Abstract][Full Text] [Related]
20. The role of hematopoietic growth factors in transfusion medicine. Whitsett CF Hematol Oncol Clin North Am; 1995 Feb; 9(1):23-68. PubMed ID: 7737944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]